Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 198.96 CNY 0.41% Market Closed
Market Cap: 120B CNY

Wall Street
Price Targets

Price Targets Summary
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Wall Street analysts forecast Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 261.46 CNY with a low forecast of 166.65 CNY and a high forecast of 312.9 CNY.

Lowest
Price Target
166.65 CNY
16% Downside
Average
Price Target
261.46 CNY
31% Upside
Highest
Price Target
312.9 CNY
57% Upside
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors:
Price Targets
4506
Sumitomo Pharma Co Ltd
23% Downside
3933
United Laboratories International Holdings Ltd
12% Upside
OGI
OrganiGram Holdings Inc
41% Upside
300119
Tianjin Ringpu Bio-Technology Co Ltd
30% Upside
4547
Kissei Pharmaceutical Co Ltd
10% Upside
2161
Jbm (Healthcare) Ltd
9% Upside
MRK
Merck & Co Inc
29% Upside
LINCOLN
Lincoln Pharmaceuticals Ltd
84% Upside

Revenue
Forecast

Revenue Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 21%. The projected CAGR for the next 3 years is 12%.

21%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 25%. The projected CAGR for the next 3 years is 15%.

25%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 2 years is 19%.

24%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's stock price target?
Price Target
261.46 CNY

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 261.46 CNY with a low forecast of 166.65 CNY and a high forecast of 312.9 CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 21%. The projected CAGR for the next 3 years is 12%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 25%. The projected CAGR for the next 3 years is 15%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 2 years is 19%.

Back to Top